Aptevo Therapeutics (APVO)
(Delayed Data from NSDQ)
$0.17 USD
-0.01 (-3.35%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.18 +0.01 (5.82%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum C VGM
Aptevo Therapeutics Inc. (APVO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$15.00 | $15.00 | $15.00 | 8,233.33% |
Price Target
Only one analyst offered a short-term price target of $15.00 for Aptevo Therapeutics Inc. This represents an increase of 8% from the last closing price of $0.18.
Analyst Price Targets (1 )
Broker Rating
Only one brokerage firm provided a Strong Buy-equivalent recommendation for Aptevo Therapeutics Inc. This translates to an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell). ABR is the calculated average of actual recommendations (Buy, Hold, Sell etc.) made by brokerage firms.
The current ABR compares to an ABR of 1.00 a month ago based on two recommendations. There were two Strong Buy recommendations a month ago.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/1/2024 | Roth Capital Partners | Jonathan Aschoff | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 1 |
Average Target Price | $15.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.64 |
APVO FAQs
Aptevo Therapeutics Inc. (APVO) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 1 brokerage firms.
The average price target for Aptevo Therapeutics Inc. (APVO) is $15.00. The current on short-term price targets is based on 1 reports.
The forecasts for Aptevo Therapeutics Inc. (APVO) range from a low of $15 to a high of $15. The average price target represents a increase of $8723.53 from the last closing price of $.17.
The current UPSIDE for Aptevo Therapeutics Inc. (APVO) is 8723.53%
Only one analyst offered a short-term price target of $15.00 for Aptevo Therapeutics Inc. This represents an increase of 8% from the last closing price of $0.18.